Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 20, Issue 11

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 20, Issue 11 (2011)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 20, Issue 11 (2011)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Volume 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Article

Insulin-like growth factor 1 receptor (IGF-1R) inhibitor: another arrow in the quiver – Will it hit the moving target?

Vivek Subbiah MD, Laura S Angelo & Razelle Kurzrock

Pages: 1471-1477

Published online: 21 Sep 2011

AbstractforInsulin-like growth factor 1 receptor (IGF-1R) inhibitor: another arrow in the quiver – Will it hit the moving target? | Full Text | References | PDF (280.2 KB)

203 Views
3 CrossRef citations
0Altmetric

Discontinued Drug Perspective

Article

Discontinued drugs in 2010: oncology drugs

Robert Williams

Pages: 1479-1496

Published online: 28 Sep 2011

AbstractforDiscontinued drugs in 2010: oncology drugs | Full Text | References | PDF (204.5 KB)

669 Views
13 CrossRef citations
0Altmetric

Reviews

Article

Road to remission: a comprehensive review of therapy in uveitis

Sana S Siddique MD, Rajiv Shah MD, Ana M Suelves MD & Charles Stephen Foster MD FACS FACR

Pages: 1497-1515

Published online: 21 Sep 2011

AbstractforRoad to remission: a comprehensive review of therapy in uveitis | Full Text | References | PDF (298.6 KB)

702 Views
31 CrossRef citations
0Altmetric

Article

Low molecular weight heparins in the treatment of lung cancer

Wouter W Mellema, Egbert F Smit & Anne-Marie C Dingemans

Pages: 1517-1522

Published online: 07 Oct 2011

AbstractforLow molecular weight heparins in the treatment of lung cancer | Full Text | References | PDF (185.3 KB)

164 Views
6 CrossRef citations
0Altmetric

Article

Dehydroaltenusin is a specific inhibitor of mammalian DNA polymerase α

Yoshiyuki Mizushina PhD, Naoki Maeda, Isoko Kuriyama & Hiromi Yoshida

Pages: 1523-1534

Published online: 17 Sep 2011

AbstractforDehydroaltenusin is a specific inhibitor of mammalian DNA polymerase α | Full Text | References | PDF (526.1 KB)

178 Views
6 CrossRef citations
0Altmetric

Article

Clinical and investigational use of proteasome inhibitors for transplant rejection

Basma Sadaka PharmD, Rita R Alloway PharmD & E Steve Woodle MD

Pages: 1535-1542

Published online: 15 Sep 2011

AbstractforClinical and investigational use of proteasome inhibitors for transplant rejection | Full Text | References | PDF (499.5 KB)

426 Views
12 CrossRef citations
0Altmetric

Article

Investigational CETP antagonists for hyperlipidemia and atherosclerosis prevention

Cesare R Sirtori MD PhD

Pages: 1543-1554

Published online: 01 Oct 2011

AbstractforInvestigational CETP antagonists for hyperlipidemia and atherosclerosis prevention | Full Text | References | PDF (440 KB)

678 Views
12 CrossRef citations
0Altmetric

Article

The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death

Ping Qiu, Xizhong Cui, Amisha Barochia, Yan Li, Charles Natanson & Peter Q Eichacker MD

Pages: 1555-1564

Published online: 01 Oct 2011

AbstractforThe evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death | Full Text | References | PDF (428.4 KB)

440 Views
72 CrossRef citations
0Altmetric

Drug Evaluations

Article

Preclinical and clinical activity of the topoisomerase I inhibitor, karenitecin, in melanoma

Pamela N Munster MD & Adil I Daud MD

Pages: 1565-1574

Published online: 11 Oct 2011

AbstractforPreclinical and clinical activity of the topoisomerase I inhibitor, karenitecin, in melanoma | Full Text | References | PDF (378.4 KB)

220 Views
26 CrossRef citations
0Altmetric

Article

Accelerated healing of diabetic wounds by NorLeu³-angiotensin (1-7)

Kathleen Rodgers PhD, Shelagh Verco PhD, Laura Bolton PhD & Gere diZerega MD

Pages: 1575-1581

Published online: 06 Oct 2011

AbstractforAccelerated healing of diabetic wounds by NorLeu³-angiotensin (1-7) | Full Text | References | PDF (419.3 KB)

266 Views
20 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.20, Iss.11, 2011)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?